Trials / Completed
CompletedNCT05055310
The Mechanism of MicroRNAs Network in Alzheimer's Disease
Shanghai Mental Health Center
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 60 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
MicroRNAs network, such as MicRNA107 et al, regulate the pathology of Alzheimer's disease and the clinical validation in diagnosis AD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MicRNAs test | plasma micRNAs concentration |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2021-09-24
- Last updated
- 2021-09-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05055310. Inclusion in this directory is not an endorsement.